(Q46116452)

19 December 2017

review article

1 reference

title

Dyslipidemia in type 2 diabetes mellitus (English)

1 reference

19 December 2017

0 references

1 reference

Arshag D Mooradian

1

1 reference

19 December 2017

publication date

1 March 2009

1 reference

19 December 2017

Nature Clinical Practice Endocrinology and Metabolism

published in

1 reference

19 December 2017

volume

5

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

page(s)

150-159

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1038/ncpendmet1066

exact match

0 references

cites work

Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

1 reference

12 December 2020

Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel

1 reference

12 December 2020

Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).

1 reference

12 December 2020

Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association

1 reference

12 December 2020

U.K. Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex

1 reference

12 December 2020

Effect of low and high fat diets on nutrient intakes and selected cardiovascular risk factors in sedentary men and women

1 reference

12 December 2020

The relationships of vigorous exercise, alcohol, and adiposity to low and high high-density lipoprotein-cholesterol levels

1 reference

12 December 2020

1 reference

12 December 2020

Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial.

1 reference

12 December 2020

Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation

1 reference

12 December 2020

Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes

1 reference

12 December 2020

The role of thiazolidinediones in the treatment of patients with type 2 diabetes mellitus

1 reference

12 December 2020

Safety and efficacy of Omacor in severe hypertriglyceridemia

1 reference

12 December 2020

The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study

1 reference

12 December 2020

Cardiovascular disease in type 2 diabetes mellitus: current management guidelines

1 reference

12 December 2020

Dyslipidemia management in adults with diabetes

1 reference

12 December 2020

Inhibition of apolipoprotein AI gene expression by tumor necrosis factor alpha: roles for MEK/ERK and JNK signaling

1 reference

12 December 2020

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

12 December 2020

The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up.

1 reference

12 December 2020

Management of diabetic dyslipidemia

1 reference

12 December 2020

Changes in high-density lipoprotein-cholesterol subfractions with exercise training may be dependent on cholesteryl ester transfer protein (CETP) genotype

1 reference

12 December 2020

Adipose tissue and the insulin resistance syndrome

1 reference

12 December 2020

Influence of glycemic load on HDL cholesterol in youth

1 reference

12 December 2020

Adiponectin is an important determinant of apoA-I catabolism.

1 reference

12 December 2020

1 reference

12 December 2020

The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes.

1 reference

12 December 2020

Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations

1 reference

12 December 2020

Current and future pharmacologic options for the management of patients unable to achieve low-density lipoprotein-cholesterol goals with statins

1 reference

12 December 2020

Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL.

1 reference

12 December 2020

Obesity: a rational target for managing diabetes mellitus

1 reference

12 December 2020

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

12 December 2020

Simvastatin with or without ezetimibe in familial hypercholesterolemia

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota Heart Survey

1 reference

12 December 2020

Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial

1 reference

12 December 2020

Ascorbic acid and alpha-tocopherol down-regulate apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines

1 reference

12 December 2020

Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins

1 reference

12 December 2020

Dual cholesterol inhibition with ezetimibe/simvastatin in pre-treated hypercholesterolaemic patients with coronary heart disease or diabetes mellitus: prospective observational cohort studies in clinical practice

1 reference

12 December 2020

Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Dietary and genetic probes of atherogenic dyslipidemia

1 reference

12 December 2020

Exercise is required for visceral fat loss in postmenopausal women with type 2 diabetes

1 reference

12 December 2020

Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides

1 reference

12 December 2020

Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study

1 reference

12 December 2020

Transcriptional control of apolipoprotein A-I gene expression in diabetes

1 reference

12 December 2020

Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

1 reference

12 December 2020

Controlling lipid levels in diabetes

1 reference

12 December 2020

Dyslipidemia in type 2 diabetes

1 reference

12 December 2020

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

12 December 2020

Diabetic dyslipidemia

1 reference

12 December 2020

Familial dyslipidaemias: an overview of genetics, pathophysiology and management

1 reference

12 December 2020

Thematic review series: patient-oriented research. Dietary fat, carbohydrate, and protein: effects on plasma lipoprotein patterns

1 reference

12 December 2020

Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study).

1 reference

12 December 2020

Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial

1 reference

12 December 2020

The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels

1 reference

12 December 2020

Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance

1 reference

12 December 2020

Low serum high-density lipoprotein cholesterol in obese subjects with normal serum triglycerides: the role of insulin resistance and inflammatory cytokines

1 reference

12 December 2020

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations

1 reference

12 December 2020

Anacetrapib: new hope for cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia

1 reference

12 December 2020

Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials

1 reference

12 December 2020

High-density lipoprotein-cholesterol, its subfractions, and responses to exercise training are dependent on endothelial lipase genotype

1 reference

12 December 2020

Pharmacologic treatment of type 2 diabetic dyslipidemia

1 reference

12 December 2020

Diabetic dyslipidaemia: from basic research to clinical practice.

1 reference

12 December 2020

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

12 December 2020

Diabetes and decline in heart disease mortality in US adults.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NCPENDMET1066

1 reference

19 December 2017

Dimensions Publication ID

1004974329

0 references

1 reference

19 December 2017